Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Philochem, a wholly owned subsidiary of Philogen, is the Discovery Unit of the Philogen group, based in Otelfingen, Zurich. Since 2006, it has pioneered innovations in ligand discovery and medicinal target identification. Key technologies include antibody isolation, immunocytokines, vascular marker discovery, and DNA-encoded chemical libraries. Integrated into drug discovery, top candidates advance to GMP production and clinic...
Philochem, a wholly owned subsidiary of Philogen, is the Discovery Unit of the Philogen group, based in Otelfingen, Zurich. Since 2006, it has pioneered innovations in ligand discovery and medicinal target identification. Key technologies include antibody isolation, immunocytokines, vascular marker discovery, and DNA-encoded chemical libraries. Integrated into drug discovery, top candidates advance to GMP production and clinical trials at Philogen. Philochem also actively collaborates with leading pharma companies through its cutting-edge platforms.

List your booth number for exhibitions, ask us